PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Etoposide
Presentation Product Chemical substance Chapter Items dispensed
Eposin 100mg/5ml concentrate for solution for infusion vials
0801040D0BCAAAD
Eposin Etoposide Malignant Disease and Immunosuppression No data available
Eposin 500mg/25ml concentrate for inf vials
0801040D0BCABAF
Eposin Etoposide Malignant Disease and Immunosuppression No data available
Etopophos 100mg powder for solution for injection vials
0801040D0BDAAAG
Etopophos Etoposide Malignant Disease and Immunosuppression No data available
Etoposide 100mg capsules
0801040D0AAABAB
Etoposide Etoposide Malignant Disease and Immunosuppression No data available
Etoposide 100mg powder for solution for injection vials
0801040D0AAAGAG
Etoposide Etoposide Malignant Disease and Immunosuppression No data available
Etoposide 100mg/5ml solution for infusion vials
0801040D0AAADAD
Etoposide Etoposide Malignant Disease and Immunosuppression No data available
Etoposide 200mg/10ml solution for infusion vials
0801040D0AAAEAE
Etoposide Etoposide Malignant Disease and Immunosuppression No data available
Etoposide 500mg/25ml solution for infusion vials
0801040D0AAAFAF
Etoposide Etoposide Malignant Disease and Immunosuppression No data available
Etoposide 50mg capsules
0801040D0AAAAAA
Etoposide Etoposide Malignant Disease and Immunosuppression No data available
Vepesid 100mg capsules
0801040D0BBABAB
Vepesid Etoposide Malignant Disease and Immunosuppression No data available
Vepesid 100mg/5ml solution for infusion vials
0801040D0BBADAD
Vepesid Etoposide Malignant Disease and Immunosuppression No data available
Vepesid 50mg capsules
0801040D0BBAAAA
Vepesid Etoposide Malignant Disease and Immunosuppression No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.